Demonstration of high opioid-like activity in isolated peptides from wheat gluten hydrolysates.
Because of a possible relationship between schizophrenia and celiac disease, a condition in some individuals who are sensitive to wheat gluten proteins in the diet, there has been interest in observations that peptides derived from wheat gluten proteins exhibit opioid-like activity in in vitro tests. To determine the origin of the peptides exhibiting opioid activity, wheat proteins were fractionated by size (gel filtration), by charge differences (ion exchange chromatography) and by differences in hydrophobicity (reversed-phase HPLC). These fractions were hydrolyzed by pepsin or pepsin and trypsin and the resulting peptides separated by gel filtration chromatography. The separated peptides were tested for opioid-like activity by competitive binding to opioid receptor sites in rat brain tissue in the presence of tritium-labeled dihydromorphine. The peptides showed considerable differences in activity; while some peptides exhibited no activity, 0.5 mg of the most active peptides were equivalent to 1 nM of morphine in the binding assay. The most active peptides were derived from the gliadin fraction of the gluten complex.
D000818:Animals; D001921:Brain / Q000378:metabolism; D002446:Celiac Disease / Q000209:etiology; D004723:Endorphins / Q000302:isolation & purification* / Q000378:metabolism; D005903:Gliadin / Q000378:metabolism; D005983:Glutens / Q000009:adverse effects / Q000032:analysis*; D006801:Humans; D006868:Hydrolysis; D066298:In Vitro Techniques; D008297:Male; D010455:Peptides / Q000302:isolation & purification* / Q000494:pharmacology; D010940:Plant Proteins / Q000378:metabolism; D051381:Rats; D011957:Receptors, Opioid / Q000378:metabolism; D012559:Schizophrenia / Q000209:etiology; D014908:Triticum
D004723:Endorphins; D010455:Peptides; D010940:Plant Proteins; D011957:Receptors, Opioid; D005983:Glutens; D005903:Gliadin; C037302:glutenin